Sequana Medical NV (EBR:SEQUA)
Belgium
· Delayed Price · Currency is EUR 1.026
-0.054 (-5.00%)
May 13, 2025, 5:25 PM CET
Sequana Medical NV Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.81 | 2.58 | 18.87 | 9.6 | 11.02 | Upgrade
|
| Cash & Short-Term Investments | 3.81 | 2.58 | 18.87 | 9.6 | 11.02 | Upgrade
|
| Cash Growth | 47.34% | -86.31% | 96.61% | -12.85% | 97.19% | Upgrade
|
| Accounts Receivable | - | 0.04 | 0.11 | 0.08 | 0.02 | Upgrade
|
| Other Receivables | 0.3 | 0.31 | 0.29 | 0.3 | 0.31 | Upgrade
|
| Receivables | 0.3 | 0.36 | 0.41 | 0.38 | 0.34 | Upgrade
|
| Inventory | 2.05 | 2.3 | 2.62 | 2.14 | 1.47 | Upgrade
|
| Prepaid Expenses | 0.26 | 1.06 | 1.19 | 0.77 | 0.62 | Upgrade
|
| Other Current Assets | 0 | 0 | - | 0 | 0 | Upgrade
|
| Total Current Assets | 6.42 | 6.3 | 23.09 | 12.89 | 13.44 | Upgrade
|
| Property, Plant & Equipment | 1.77 | 2.32 | 2.07 | 1.27 | 0.7 | Upgrade
|
| Long-Term Investments | 0.1 | 0.1 | 0.09 | 0.08 | 0.07 | Upgrade
|
| Other Long-Term Assets | 1.65 | 1.39 | 0.78 | 0.46 | -0 | Upgrade
|
| Total Assets | 9.94 | 10.1 | 26.03 | 14.71 | 14.21 | Upgrade
|
| Accounts Payable | 1.89 | 2.74 | 3.23 | 2.19 | 2.01 | Upgrade
|
| Accrued Expenses | 2.47 | 3.37 | 3.51 | 2.52 | 1.3 | Upgrade
|
| Current Portion of Long-Term Debt | 39.7 | 7.82 | 4.48 | - | - | Upgrade
|
| Current Portion of Leases | 0.06 | 0.27 | 0.31 | 0.28 | 0.26 | Upgrade
|
| Current Unearned Revenue | - | 0.17 | 0.16 | 0.17 | 0.79 | Upgrade
|
| Other Current Liabilities | 9.1 | 5.1 | 3.45 | 2.01 | 1.6 | Upgrade
|
| Total Current Liabilities | 53.21 | 19.47 | 15.15 | 7.18 | 5.97 | Upgrade
|
| Long-Term Debt | - | 8.97 | 12.19 | 7.32 | 7.47 | Upgrade
|
| Long-Term Leases | 0.36 | 0.46 | 0.61 | 0.48 | 0.12 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0 | Upgrade
|
| Total Liabilities | 54.32 | 29.57 | 28.18 | 15.49 | 14.1 | Upgrade
|
| Common Stock | 4.6 | 2.93 | 2.46 | 1.92 | 1.64 | Upgrade
|
| Additional Paid-In Capital | 201.56 | 185.64 | 170.32 | 142.43 | 119.33 | Upgrade
|
| Retained Earnings | -250.68 | -206.02 | -173.46 | -142.7 | -119.08 | Upgrade
|
| Comprehensive Income & Other | 0.13 | -2.01 | -1.48 | -2.45 | -1.77 | Upgrade
|
| Shareholders' Equity | -44.38 | -19.47 | -2.15 | -0.79 | 0.11 | Upgrade
|
| Total Liabilities & Equity | 9.94 | 10.1 | 26.03 | 14.71 | 14.21 | Upgrade
|
| Total Debt | 40.11 | 17.52 | 17.59 | 8.09 | 7.86 | Upgrade
|
| Net Cash (Debt) | -36.3 | -14.94 | 1.28 | 1.52 | 3.16 | Upgrade
|
| Net Cash Growth | - | - | -15.34% | -52.00% | 33.66% | Upgrade
|
| Net Cash Per Share | -0.99 | -0.56 | 0.06 | 0.08 | 0.21 | Upgrade
|
| Filing Date Shares Outstanding | 52.87 | 35.91 | 23.75 | 23.75 | 18.54 | Upgrade
|
| Total Common Shares Outstanding | 44.44 | 28.24 | 23.75 | 18.58 | 15.78 | Upgrade
|
| Working Capital | -46.79 | -13.17 | 7.94 | 5.71 | 7.48 | Upgrade
|
| Book Value Per Share | -1.00 | -0.69 | -0.09 | -0.04 | 0.01 | Upgrade
|
| Tangible Book Value | -44.38 | -19.47 | -2.15 | -0.79 | 0.11 | Upgrade
|
| Tangible Book Value Per Share | -1.00 | -0.69 | -0.09 | -0.04 | 0.01 | Upgrade
|
| Machinery | 1.69 | 1.69 | 1.52 | 0.9 | 0.67 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.